🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/12/2007 | 56,59 | 57,18 | 56,04 | 57,05 | +0,12% | 2,01% | 9.398.569 |
| 12/12/2007 | 58,21 | 58,80 | 56,37 | 56,98 | -1,13% | 4,16% | 22.524.874 |
| 11/12/2007 | 58,20 | 58,50 | 57,38 | 57,63 | -0,61% | 1,93% | 12.975.183 |
| 10/12/2007 | 57,89 | 58,19 | 57,18 | 57,99 | +0,16% | 1,75% | 11.940.807 |
| 07/12/2007 | 56,77 | 58,29 | 56,54 | 57,89 | +1,97% | 3,09% | 12.496.352 |
| 06/12/2007 | 57,04 | 57,20 | 56,31 | 56,77 | +0,17% | 1,57% | 10.454.429 |
| 05/12/2007 | 55,77 | 56,90 | 55,24 | 56,68 | +1,73% | 2,98% | 11.433.470 |
| 04/12/2007 | 54,76 | 56,41 | 53,97 | 55,72 | -0,65% | 4,46% | 20.122.962 |
| 03/12/2007 | 56,07 | 56,77 | 55,94 | 56,08 | -0,99% | 1,46% | 9.902.028 |
| 30/11/2007 | 57,44 | 57,72 | 56,25 | 56,64 | -0,93% | 2,56% | 19.403.825 |
| 29/11/2007 | 57,06 | 57,53 | 56,65 | 57,18 | -0,07% | 1,54% | 12.765.793 |
| 28/11/2007 | 56,55 | 57,26 | 56,14 | 57,21 | +1,73% | 1,99% | 20.290.852 |
| 27/11/2007 | 54,74 | 57,25 | 54,74 | 56,24 | +2,34% | 4,58% | 19.122.646 |
| 26/11/2007 | 55,01 | 55,74 | 54,22 | 54,95 | -0,12% | 2,78% | 15.960.516 |
| 23/11/2007 | 54,18 | 55,24 | 54,18 | 55,02 | +2,02% | 1,95% | 7.040.569 |
| 21/11/2007 | 54,70 | 54,91 | 52,99 | 53,93 | -2,42% | 3,52% | 13.831.190 |
| 20/11/2007 | 55,56 | 55,73 | 54,71 | 55,27 | -0,57% | 1,82% | 14.977.597 |
| 19/11/2007 | 55,25 | 55,92 | 55,14 | 55,58 | -0,22% | 1,40% | 14.248.608 |
| 16/11/2007 | 55,75 | 55,75 | 54,50 | 55,71 | +0,79% | 2,24% | 13.664.034 |
| 15/11/2007 | 54,35 | 56,19 | 54,24 | 55,27 | +1,08% | 3,60% | 16.544.357 |
| 14/11/2007 | 53,91 | 55,04 | 53,91 | 54,68 | -0,33% | 2,09% | 10.995.721 |
| 13/11/2007 | 53,84 | 54,90 | 53,43 | 54,86 | +2,68% | 2,73% | 16.533.248 |
| 12/11/2007 | 53,35 | 54,07 | 52,80 | 53,43 | +0,16% | 2,40% | 11.320.810 |
| 09/11/2007 | 52,98 | 55,10 | 52,98 | 53,34 | +2,06% | 4,00% | 26.584.616 |
| 08/11/2007 | 51,97 | 52,62 | 51,58 | 52,26 | +1,05% | 2,00% | 18.793.574 |
| 07/11/2007 | 52,66 | 53,37 | 51,65 | 51,72 | -3,20% | 3,26% | 14.087.111 |
| 06/11/2007 | 53,42 | 53,69 | 53,13 | 53,43 | +0,11% | 1,05% | 9.805.822 |
| 05/11/2007 | 52,48 | 54,25 | 52,48 | 53,37 | -0,20% | 3,36% | 12.336.637 |
| 02/11/2007 | 55,38 | 55,38 | 53,02 | 53,47 | -2,30% | 4,26% | 17.646.958 |
| 01/11/2007 | 55,23 | 55,69 | 54,57 | 54,73 | -1,54% | 2,02% | 12.644.749 |